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Abstract
Background/Objectives—Central adiposity measures such as waist circumference (WC) and 
waist-to-hip ratio (WHR) are associated with cardiometabolic disorders independently of BMI and 
are gaining clinically utility. Several studies report genetic variants associated with central 
adiposity, but most utilize only European ancestry populations. Understanding whether the genetic 
associations discovered among mainly European descendants are shared with African ancestry 
populations will help elucidate the biological underpinnings of abdominal fat deposition.
Subjects/Methods—To identify the underlying functional genetic determinants of body fat 
distribution, we conducted an array-wide association meta-analysis among persons of African 
ancestry across seven studies/consortia participating in the Population Architecture using 
Genomics and Epidemiology (PAGE) consortium. We used the Metabochip array, designed for 
fine mapping cardiovascular associated loci, to explore novel array-wide associations with WC 
and WHR among 15 945 African descendants using all and sex-stratified groups. We further 
interrogated 17 known WHR regions for African ancestry-specific variants.
Results—Of the 17 WHR loci, eight SNPs located in four loci were replicated in the sex-
combined or sex-stratified meta-analyses. Two of these eight independently associated with WHR 
after conditioning on the known variant in European descendants (rs12096179 in TBX15-WARS2 
and rs2059092 in ADAMTS9). In the fine mapping assessment, the putative functional region was 
reduced across all four loci but to varying degrees (average 40% drop in number of putative SNPs 
and 20% drop in genomic region). Similar to previous studies, the significant SNPs in the female 
stratified analysis were stronger than the significant SNPs from the sex-combined analysis. No 
novel associations were detected in the array-wide analyses.
Conclusions—Of 17 previously identified loci, four loci replicated in the African ancestry 
populations of this study. Utilizing different linkage disequilibrium patterns observed between 
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European and African ancestries, we narrowed the suggestive region containing causative variants 
for all four loci.
INTRODUCTION
Waist-related traits such as waist-to-hip ratio (WHR) and waist circumference (WC) are 
common measures of central adiposity – a risk factor of cardiovascular and metabolic 
disease. WC may better predict type 2 diabetes mellitus in comparison to overall adiposity 
(BMI) and greater hip circumference potentially associates with lower risk of cardiovascular 
diseases, particularly among women.1–4 In the U.S., while the increase in overall obesity 
prevalence has slowed,5 the average WC continues to increase6 and obesity (overall and 
central) continues to disproportionally burden minority groups such as African 
Americans.7, 8 According to a recent report by the Centers for Disease Control, the 
demographic group with the highest prevalence of obesity is non-Hispanic African 
American women (57% obese).9
Though obesity is higher among many minority groups, most genetic studies have focused 
on European descendant populations, and any benefits reaped from genetic studies may only 
be applicable and benefit European descendants. In addition, due to high linkage 
disequilibrium (LD) in European ancestry groups, the single nucleotide polymorphisms 
(SNPs) identified in European ancestry genome wide association studies (GWAS) often only 
point to general genomic areas of interest and the causal functional variants remain elusive. 
A greater refinement of genomic regions containing putative functional variants is possible 
by utilizing different LD patterns among various ancestry populations, particularly the 
relatively low LD among African descendants.10
We aimed to refine the genomic regions containing the functional genetic determinants of 
body fat distribution by conducting an array-wide association analysis among African 
descendants. For genotyping, we used a chip (Metabochip) uniquely poised to refine 
genomic regions of interest due its custom design densely covering cardiovascular related 
genomic regions of interest, including 17 genetic regions associated with waist-to-hip ratio 
adjusted for BMI (WHRa).11
MATERIALS AND METHODS
Participant recruitment and study population
Participants were recruited from studies involved in the PAGE consortium – a consortium 
initiated by the National Human Genome Research Institute (NHGRI) specially designed to 
investigate well-replicated genetic variants among racially and ethnically diverse populations 
in the U.S as described elsewhere.12 For this PAGE Metabochip study, all cohorts with 
African American participants and waist-related traits were included for the analyses, which 
consisted of the Atherosclerosis Risk in Communities (ARIC) study, Coronary Artery Risk 
Development in Young Adults (CARDIA) study, the Cardiovascular Health Study (CHS), 
the Multiethnic Cohort Study (MEC), and the Women’s Health Initiative (WHI). We also 
extended the collaboration to three additional studies – GenNet, Hypertension Genetic 
Epidemiology Network (HyperGen), and the Multi-Ethnic Study of Atherosclerosis 
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(MESA), which brought up the total sample size to 15 945 (see Supplementary Information 
and Supplementary Table S1 for detailed study descriptions). All studies were approved by 
Institutional Review Boards at their respective sites. All participants in this analyses 
provided written informed consent and self-identified as African American or having 
African ancestry.
Anthropometry measurements
Weight, height, WC and hip circumference were measured by trained staff at study 
enrollment in a clinical setting for studies ARIC, CARDIA, CHS, HyperGEN, GenNet, 
MESA, and WHI. MEC participants provided self-reported height and weight and self-
measured WC and hip circumference. In a MEC validation subset, self-measured 
circumferences were highly correlated with technician measurements for waist (r=0.93), hip 
(r=0.96), and WHR (r=0.76) and slightly underestimated the waist (by 3.95cm) and hip (by 
0.1cm) circumferences.13 Other studies have similarly shown correlations above 0.8614–16 
and small systematic mismeasurement between self-reported and measured anthropometry, 
which may reduce detection power of WC or WHR associated variants but not bias the 
associations in self-reported data.14, 17, 18
BMI was calculated by dividing weight (kg) by height (m2) and WHR was calculated by 
dividing waist circumference (cm) by hip circumference (cm). We excluded, underweight 
(BMI<18.5 kg/m2) and extreme overweight (BMI>70 kg/m2) individuals and those with 
outlier WC and WHR values (SD > 3) with the assumption that these extremes could be 
attributable to data coding errors or underlying rare conditions with contributions from 
genetic variants not common to the general population. We also limited analysis to 
individuals aged 20 years or above to exclude the adolescent age period where weight and 
height can fluctuate dramatically and increase variability.
Genotyping and quality control
Genotyping was performed using the Metabochip – a chip with more than 122 000 SNPs 
included to fine-map 257 GWAS loci of 23 traits. The Metabochip design, trait selection, 
and locus definition has been described elsewhere.19 Of the 257 loci, fourteen WHRa GWAS 
loci were included on the array and were the main focus of the current study. After the 
completion of the Metabochip design, another large-scale GWAS on WHR by Shungin et 
al.20 identified 33 additional novel WHRa SNPs. We cross checked whether these 33 SNPs 
overlapped with other Metabochip fine-mapping regions and found three more loci initially 
placed on the Metabochip for other trait investigation (triglycerides, systolic blood pressure, 
and QT interval). The additional three loci increased our target loci to 17 (Supplementary 
Table S2). Further quality control information available elsewhere21 and Supplementary 
Table S3.
For all studies, with the exception of family based studies (HyperGen and GenNet), we 
estimated identical-by-descent statistics to identify related persons using PLINK.22 For each 
first-degree relative pairs identified, we excluded the member with the lower call rate. We 
also excluded samples with an inbreeding coefficient (F) above 0.15 (ARIC, CHS, 
CARDIA, MEC, MESA, WHI).23 As described elsewhere,21,24 ancestral outliers were 
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determined visually against HapMap phase 2 reference populations (Supplementary Figure 
S1), in addition to EIGENSOFT25,26 determination of outliers (any first ten principal 
components with SD > 6). Ancestral principal components were then recalculated separately 
for each study excluding HapMap genotypes.
Statistical analysis
The overall study design are depicted in Figure 1. We evaluated the association between 
each SNP and natural log-transformed WC and WHR with adjustment for BMI (WCa and 
WHRa respectively). Due to the high sex dimorphism noted in several studies on WHR 
associated SNPs,11, 27–30 we conducted the association analyses in sex stratified groups as 
well (sex-combined, females-only, and males-only) in each study. For all studies except 
GenNet and HyperGen (family studies), we used linear regression under the assumption of 
an additive genetic model with the adjustment for BMI, age, sex, age*sex (for sex-combined 
analyses only), study site (as applicable), and ancestry principal components in each study. 
Any overly influential outliers were removed. Family data from GenNet and HyperGen were 
analyzed using linear mixed models to account for relatedness.31 As a sensitivity analysis, 
we analyzed MEC using all participants combined and also separately by case-control status 
for diabetes (390 cases, 667 controls). However, there was little difference between the 
meta-analyzed results (Supplementary Figure S2); therefore, we present meta-analyses from 
all studies including all MEC participants.
Fixed-effect models with inverse variance weighting were used to pool the study-specific 
association results as implemented in METAL.32 Chi-square statistics and I2 were used to 
measure heterogeneity across studies, and SNPs with chi-square heterogeneity P-value <0.05 
or I2 > 50 were excluded. When testing all SNPs Metabochip-wide for SNPs with significant 
association with WCa or WHRa, we used a Bonferroni adjusted significance level based on 
the total number of SNPs on the chip, 2.5×10−7 (0.05 divided by 200,000 SNPs).
For the 17 WHRa regions of interest (Supplementary Information, Supplementary Table S2), 
we first interrogated the genome-wide significant SNP from Heid et al.11 or Shungin et al.20 
which we labeled the “index SNP”. If the SNP shared directional consistency in both 
European and African ancestry populations and showed nominal statistical significance (P-
value<0.05) in our meta-analyses, we classified the index SNP as “generalized”.
Due to the decreased LD in populations of African ancestry,33, 34 we also hypothesized that 
even if the index SNP originally identified in European ancestry populations was not 
associated with WHRa for those within our African ancestral cohort, another variant in the 
same chromosomal region may show strong associations: “lead SNPs”. Therefore, we 
searched for common variants strongly associated with WHRa within the established loci 
and differentiated whether the identified SNPs were “index-dependent lead signals” or 
“index independent lead signals”. We identified lead SNPs as index-dependent signals (thus 
potentially better markers of the index signal) if they were (1) within the defined WHRa 
region of the index SNP as defined on the Metabochip19, (2) dependent on the index SNP 
(r2≥0.4) based on the referent population (CEU), and (3) associated with WHRa in our data 
at a Bonferroni significance level, correcting for the average number of SNPs across the 17 
regions tested (P-value<9.97×10−5). We identified lead SNPs as index-independent signals if 
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they (1) were within the defined WHRa region, (2) had an r2<0.4 of the index SNP based on 
CEU LD, (3) displayed a region wide significance (P-value<9.97×10−5) and 4) after 
controlling for the index SNP using approximate conditional analysis methods35, had 
retained a P-value of at least 9.97×10−5.
LD in the African American sample (including African Americans from ARIC, MEC, and 
WHI) was calculated in 500kb sliding windows using PLINK.22 Likewise, Metabochip LD 
and frequency information in Europeans was provided by the Malmö Diet and Cancer Study 
on 2143 controls from a Swedish population36 to facilitate the LD pattern comparisons 
between African and European ancestry populations. LocusZoom plots37 were used to 
graphically display the fine-mapping results. Recombination rates were estimated from 
1000G Project data.
Given our sample size (~16 000), we are reasonably powered (80%) to detect common SNPs 
(30%) with average effect sizes (0.003), but are underpowered to detect lower frequency 
variants (<10%) (Supplementary Information).
Comparison with other published lead SNPs
Several GWAS in European descent populations have identified different SNPs in the 17 
loci38, 39 than those reported by Heid et al.11 Additionally, two discovery studies in African 
descent populations also identified other SNPs.27, 28 We compared our lead SNPs to the 
significant SNPs identified in these previous studies and assessed independence of the 
signals by conditional analyses when the LD was r2<0.4 using the 1000G CEU structure. We 
additionally estimated the amount of narrowing each WHRa region by contrasting all SNPs 
in high LD (r2 > 0.8) with the significant SNPs using the 1000G YRI LD structure and the 
1000G CEU LD structure.
Genotype-tissue expression lookups
We collected association values between genetic variation and gene expression in human 
tissues using the Genotype-Tissue Expression (GTEx)40 database. The database offers 
expression quantitative trait locus (eQTL) mapping in several different tissues. We focused 
on subcutaneous adipose and skeletal muscle tissues (plausible target tissues for the waist 
size variants) to estimate eQTL. For the four loci where we identified a significant SNP (P-
value<9.97×10−5), we found association strengths between our lead SNPs or other reported 
SNPs13,14,17,18,19 and the expression of genes lying within +/−500kb. We used a Bonferroni 
correction based on the number of SNPs and tissues and genes tested for each locus. For 
example, for the TBX15-WARS2 locus, we tested five SNPs in two tissues with expression 
in three different genes (TBX15, WARS2, and RP11-418J17.1), making our P-value cut-off 
0.00167 (P-value < 0.05/(5*2*3)).
RESULTS
Up to 15 945 African ancestry participants from eight studies were included in the meta-
analyses with a mean age of 55 years in women and 48 years in men (range 20 to 100 years; 
Supplementary Information, Supplementary Table S1). Approximately 77% of participants 
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were females. On average, females had lower WHR and WC (WHR=0.85, WC=97.5 cm) in 
comparison to men (WHR=0.9, WC=98 cm).
In our Metabochip-wide analyses of the WCa trait, no SNPs reached array wide significance. 
In our analyses of the WHR and WHRa trait, only one SNP (rs2059092 SNP in ADAMTS9; 
β[SE]=0.0072 [0.0014]; P-value=9.98×10−8) reached array-wide significance for WHRa in 
the female stratified analysis. Minimal inflation was observed in the analyses (inflation 
factor λ<1.1) (Supplementary Figure S3).
Sex-specific Fine Mapping of Metabochip Regions for WHR
When we focused on fine mapping of the 17 known WHRa loci in European ancestry 
populations, our female-specific analysis (Supplementary Information, Supplementary Table 
S2) showed that 13 of the 17 index SNPs had directional consistency in the effect estimates 
(binominal distribution P-value = 0.005) with the lead SNP for the region. Of the 17 known 
WHR regions on the Metabochip, four loci (in or near TBX15-WARS2, GRB14, 
ADAMTS9, and RSPO3) contained a lead SNP associated with WHRa at our Bonferonni 
corrected significance threshold of P-value<9.97×10−5 in this African ancestry sample 
(Table 1, Supplementary Information, and Supplementary Figures S4–7). The lead SNP in 
RSPO3 (rs9491696) was also the index SNP previously identified in the European ancestry 
discovery study.14 The lead SNP near the locus GRB14 has strong LD (r2=0.806 using 
1000G CEU LD) with the index SNP. The lead SNP in the TBX15-WARS2 locus had a LD 
r2 of 0.326 with the index SNP, and the lead SNP in the ADAMTS9 locus had a LD r2 of 
0.056 with the index SNP of the same locus. Of the three significant lead SNPs, only 
rs2059092 showed attenuation in significance after adjusting for the index SNP (rs6795735) 
but remained significant (P-value before conditioning = 9.98×10−8, P-value after 
conditioning = 1.23×10−6) indicating that the lead SNP in the ADAMTS9 locus points to an 
independent signal (Table 2).
In the male-specific analysis (Supplementary Information and Supplementary Table S5), 
nine of the 17 index SNPs showed directional consistency in effect estimates (binominal 
distribution P-value = 0.183), and two index SNPs showed nominal significance (P-
value<0.05). Only one of the 17 loci contained a lead SNP reaching significance (rs7412918 
in TBX15-WARS2, P-value = 2.47×10−5) (Table 1). The lead SNP from the TBX15-WARS2 
locus was in low LD with the index SNP (r2=0.24) and therefore was followed up with a 
conditional analysis. The lead SNP in TBX15-WARS2 for the male-only analysis was in a 
different gene than that of the index SNP (WARS2 instead of TBX15), yet strength of the 
association between the lead SNP and WHRa was attenuated after conditioning on the index 
SNP (P-value=2.47×10−5 before conditioning, P-value=5.80×10−4 after conditioning), 
suggesting they are identifying the same signal and makes the determination of which gene 
contains the true signal difficult (Table 2).
Sex-combined Fine Mapping of Metabochip Regions for WHR
In the sex-combined analysis, 12 out of the 17 index SNPs displayed effect estimates 
directionally consistent with estimates from Heid et al.11 (binomial distribution P-value = 
0.02) (Supplementary Information, Supplementary Table S6).
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For two loci, the index SNPs (rs10195252 near GRB14 and rs9491696 in RSPO3) displayed 
statistical evidence for generalization (directional consistency and P-value<9.97×10−5), 
while three other index SNPs (in or near TBX15-WARS2, LYPLAL1, and LY86) showed 
nominal statistical significance (p<0.05). For the RSPO3 locus there was another lead SNP, 
rs9321069, that was slightly more significant than the index SNP and had an r2<0.4 in CEU, 
thus we conditioned it on the index SNP. However, after conditioning on the index SNP, 
rs9491069 was no longer significant. Three loci (rs12096179 near TBX15-WARS2, 
rs2059092 in ADAMTS9, and rs9491069 in RSPO3) harbored a lead SNP that was in LD 
(r2<0.4) with the previously identified index SNP in European descent populations, thus we 
considered these possible index-independent SNPs. For the rs12096179 SNP in TBX15-
WARS2 and rs2059092 in ADAMTS9, conditioning on the respective index SNP in these 
loci did not diminish their significance (Table 2), indicating these are independent signals.
Comparison with other published lead SNPs
We compared this study’s lead SNPs to previously reported WHRa SNPs in four loci (for 
full comparison results see Supplementary Information, Supplementary Table S7, and 
Supplementary Figures S8a–d, 9–12). The TBX15-WARS2 locus on chromosome 1 
(position on Build36: 119.25 to 119.58 Mb), spans across the genes TBX15, WARS2, and 
RP11-418J17.1, a long non-coding RNA. To date, two SNPs in the TBX15-WARS2 locus 
have been associated with WHRa in the literature (the index SNP, rs984222,11 and the 
African ancestry discovery SNP, rs1092371428), to which we detected three additional 
SNPs; one each from the sex-combined (rs12096179), female (rs6701378), and male 
(rs7412918) analyses. Among these five SNPs, we identified one potentially independent 
signal: the sex-combined SNP (rs12096179) association with WHRa remains strong after 
conditioning on the index SNP from the literature (rs984222) (Table 2 and Supplementary 
Information, Supplementary Table S8). Importantly, fine mapping at this locus, using the 
YRI LD structure, reduces the number of putative SNPs from 37 to 24 SNPs and covers a 
20kb region, reducing the regional space harboring the functional variant by 8% (Table 3).
The GRB14 locus on chromosome 2 (position on Build36 165.21 to 165.28Mb), stretches 
across the genes GRB14, COBLL1, SNORA70F and TCONS_00004484 (a long non-coding 
RNA). In the GRB14 locus, the two SNPs from our analyses and all five published SNPs are 
in high LD with one another (r2 > 0.7) and point to a single signal. Using the CEU LD 
structure, 16 SNPs have a LD r2 of 0.8 or greater with any of the four significant SNPs and 
span across approximately 53kb. In contrast, using the YRI LD structure, 12 SNPs have a 
LD r2 of 0.8 or greater with any of the four significant SNPs and span across approximately 
43kb, narrowing the region by 19% (Table 3).
The ADAMTS9 locus in chromosome 3 (position on Build36: 64.67Mb to 64.71Mb), spans 
across the ADAMTS9-AS2, an anti-sense noncoding RNA, and microRNA, MIR548A2. 
The index SNP, rs6795735, identified in CEU by Heid et al14 is conditionally independent of 
the sex-combined and female lead SNP identified in this study (Table 2). Overall, 45 SNPs 
are in high CEU LD (r2 > 0.8) with these lead SNPs as compared to only seven SNPs that 
are in high YRI LD. Using the physical genomic region to assess the narrowing of a signal 
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region, the 45 SNPs span over ~30kb whereas the seven SNPs span over ~16kb, thus the 
region is narrowed by 45.1% (Table 3).
The RSPO3 locus on chromosome 6 (position on Build36: 127.42 to 127.57 Mb) includes 
the AK127272 and the RSPO3 genes. In reviewing previous studies, we found five SNPs in 
the RSPO3 locus that have been associated with WHRa. We contribute an additional WHRa 
SNP (rs9321069 from the sex-combined analysis) to the list. All six SNPs are conditionally 
dependent on one another and therefore appear to be tagging the same signal 
(Supplementary Information, Supplementary Table S8). Treating these six SNPs as a single 
signal and comparing the CEU LD to the YRI LD structure, we narrowed the pool of 
potentially functional SNPs from 95 SNPs down to 68 SNPs, though only reduced the 
purported functional variant region by 8% (Table 3).
Genotype-tissue expression associations
We assessed the association of our lead SNPs and other reported SNPs detected in the four 
WHRa regions with expression of genes lying within +/-500kb of the lead SNP (for full 
description of results see Supplementary Information and Supplementary Table S9). For the 
TBX15-WARS2 region, we identified significance within the WARS2 gene in skeletal 
muscle for two SNPs, rs7412918 identified in the current study, and the previously identified 
rs984222. For the locus in and near GRB14-COBLL1 genes, we identified significance 
within the SLC38A11 gene in skeletal muscle for three SNPs, rs6717858 rs13389219, and 
rs1128249. The latter eQTL, rs1128249-SLC38A11, was also significant in adipose tissue as 
well (P-value =0.001). For the loci in and near ADAMTS9 and RSPO3, no eQTLs were 
significant.
DISCUSSION
Interrogation of 17 previously reported European descent loci
We interrogated 17 previously identified genomic regions associated with WHRa in a large 
sample of African ancestry participants. Among the 17 WHRa loci, we found at least one 
significant lead SNP in either the sex-combined, female, or male only analyses. Notably, the 
lead SNP (rs10195252) in the GRB14 locus for the sex-combined analysis was the same as 
the Heid et al. index SNP identified in European descent populations. Similarly in RSPO3, 
the lead SNP in the female-only analysis (rs9491696) was also the same as the Heid et al. 
index SNP. The lack of significant SNPs in the other 13 loci may be due to low power to 
detect genetic effects and the small relative sample sizes rather than true lack of 
generalization. Power calculations using our sample size (N ~16 000) compared to the Heid 
et al. sample size (N ~ 100 000) show diminished ability to detect variants (Supplementary 
Information).
An advantage of using the custom Metabochip, unlike previous array-wide investigations of 
WHRa, is the inclusion of 1000G SNPs on the Metabochip and therefore their direct 
characterization. We were able to densely genotype both rare and common SNPs in specific 
regions of the genome that contained variants highly associated with WHR. While we did 
not identify any novel independent signals, we were able to narrow the purported region 
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containing the functional variant due to the dense mapping and comparison of the CEU LD 
to the YRI LD.
Another advantage of using the Metabochip is that some of the LD regions extended beyond 
the traditional 250 kb flanking region of the Heid et al. index SNP. Because African descent 
populations have lower LD, previous investigations have traditionally explored only the 250 
kb flanking regions of identified variants, whereas in European descent populations, 
investigators have explored a larger 500 kb flanking region. However, in our investigation, 
we found significant SNPs in African ancestry populations can span over a wide interval of 
the genome (e.g. SNPs identified in the TBX15-WARS2 locus spanned across the 330kb 
locus region). Future studies may consider looking beyond 250 kb, even in ancestral 
populations with lower LD.
Sex heterogeneity
The lead SNPs in GRB14 and ADAMTS9 were stronger in the female only analysis 
compared to the lead SNP in the sex-combined analysis. Additionally, the effect estimates 
for the lead SNPs identified in the female-only analysis were larger than the effect estimates 
of the lead SNPs identified in the sex-combined analysis. This finding is similar to 
observations made by Heid et al.11 Direct comparison of the female-specific and male-
specific results are difficult due to the large disparity in sample size, but the results are 
similar to previous studies which have found that the signals from the male-only analysis 
have lower effect sizes and are less significant in comparison to the female-only analysis. 
The reasoning for strong sex-heterogeneity observations is still unclear, though sex 
differential regulation factors, transcripts, metabolites, and microbes have been 
observed.41–43 Variant interaction with these factors may lead to larger impacts on WHRa in 
one sex group over the other.
Biologic function of identified genomic regions
In addition to using differences in ancestral LD patterns to narrow a genomic region, we 
assessed whether any genes or variants within the genomic region have any biological 
plausibility in affecting WHR. While several SNP variants may affect functionality, 
unfortunately, based on the available bioinformatics data, no definitive functional SNPs were 
identified (for full function description see Supplementary Information and Supplementary 
Table S10). A possible limitation is the current lack of experiments on specific tissue 
samples that would be relevant to WHR. While data from over 1600 experiments have been 
added to the ENCODE project, only a few experiments have been run on normal karyotype 
tissue samples of adipose, liver, and pancreas tissues. Since chromatin shape and regulation 
is known to be tissue specific, understanding whether a genetic variant affects function is 
limited to the cell lines that have been given first priority in the ENCODE project.
CONCLUSION
Fine-mapping of previously identified WHR loci produced variable results among African 
ancestry populations: some loci produced lead SNPs identical to the index SNPs from 
European ancestries, some loci where the identified SNPs were conditionally dependent on 
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the index SNPs, and a couple of loci had lead SNPs independent of the index signal. Out of 
the 17 loci, four loci generalized to the African ancestry population in our study, suggesting 
that at least some of the biologic pathways that affect WHR are shared across race and 
ethnic groups. More importantly, this study demonstrates the utility of fine-mapping regions 
which may contain functional variants. Further analyses in various multi-racial and ethnic 
groups are likely to provide a more complete picture of how the associated loci contribute to 
waist-related traits. Importantly, a clearer understanding of the genetic underpinnings of 
central adiposity may help elucidate molecular pathways that affect obesity, which in turn 
may help improve interventions and drug development.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Analysis flow chart. This diagram shows the main steps used in the meta-analysis. The 
rectangular box shows steps for SNPs reaching array-wide significance. Shaded boxes show 
steps for SNPs reaching locus-wide significance, including the further locus interrogation 
through conditional analyses, fine-mapping, and bioinformatics interrogation.
*WCa: Waist circumference adjusted for BMI; WHRa: Waist-to-hip ratio adjusted for BMI
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